BIG DATA HELPS PHARMA COMPANIES DESIGN DRUGS, BUT CHALLENGES ABOUND
June 8th, 2014
Big data is creating a growing range of opportunities that can help the global pharmaceutical industry develop and manufacture drugs more effectively. However, the industry faces a number of challenges in the way it manages and analyses the increasingly broad range of data that is available, with collaboration essential for the industry to capitalise on the potential of the big data explosion. That was the key message from an inaugural Big Data in Pharma conference, organised by business information company SMi and held in London on May 12-13.A key focus of the ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.